Avadh Sugar & Energy Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 8:02 am

Competitors of Avadh Sugar & Energy Ltd

All Competitor Stocks of Avadh Sugar & Energy Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:20 pm

Below is a detailed analysis of the quarterly data for Avadh Sugar & Energy Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 716.61 Cr.. The value appears strong and on an upward trend. It has increased from 678.78 Cr. (Mar 2025) to 716.61 Cr., marking an increase of 37.83 Cr..
• For Expenses, as of Jun 2025, the value is 688.38 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 529.50 Cr. (Mar 2025) to 688.38 Cr., marking an increase of 158.88 Cr..
• For Operating Profit, as of Jun 2025, the value is 28.23 Cr.. The value appears to be declining and may need further review. It has decreased from 149.28 Cr. (Mar 2025) to 28.23 Cr., marking a decrease of 121.05 Cr..
• For OPM %, as of Jun 2025, the value is 3.94%. The value appears to be declining and may need further review. It has decreased from 21.99% (Mar 2025) to 3.94%, marking a decrease of 18.05%.
• For Other Income, as of Jun 2025, the value is 0.30 Cr.. The value appears strong and on an upward trend. It has increased from -0.66 Cr. (Mar 2025) to 0.30 Cr., marking an increase of 0.96 Cr..
• For Interest, as of Jun 2025, the value is 26.13 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 24.01 Cr. (Mar 2025) to 26.13 Cr., marking an increase of 2.12 Cr..
• For Depreciation, as of Jun 2025, the value is 14.99 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.71 Cr. (Mar 2025) to 14.99 Cr., marking an increase of 0.28 Cr..
• For Profit before tax, as of Jun 2025, the value is -12.59 Cr.. The value appears to be declining and may need further review. It has decreased from 109.90 Cr. (Mar 2025) to -12.59 Cr., marking a decrease of 122.49 Cr..
• For Tax %, as of Jun 2025, the value is -33.20%. The value appears to be improving (decreasing) as expected. It has decreased from 34.77% (Mar 2025) to -33.20%, marking a decrease of 67.97%.
• For Net Profit, as of Jun 2025, the value is -8.41 Cr.. The value appears to be declining and may need further review. It has decreased from 71.68 Cr. (Mar 2025) to -8.41 Cr., marking a decrease of 80.09 Cr..
• For EPS in Rs, as of Jun 2025, the value is -4.20. The value appears to be declining and may need further review. It has decreased from 35.81 (Mar 2025) to -4.20, marking a decrease of 40.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:43 am

Growth

Last Updated: September 5, 2025, 12:05 am

Balance Sheet

Last Updated: May 13, 2025, 3:50 pm

Below is a detailed analysis of the balance sheet data for Avadh Sugar & Energy Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,081.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,008.00 Cr. (Mar 2024) to 1,081.00 Cr., marking an increase of 73.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,371.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,317.00 Cr. (Mar 2024) to 1,371.00 Cr., marking an increase of 54.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 408.00 Cr.. The value appears to be improving (decreasing). It has decreased from 508.00 Cr. (Mar 2024) to 408.00 Cr., marking a decrease of 100.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,880.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,854.00 Cr. (Mar 2024) to 2,880.00 Cr., marking an increase of 26.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,221.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,187.00 Cr. (Mar 2024) to 1,221.00 Cr., marking an increase of 34.00 Cr..
• For CWIP, as of Mar 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 88.00 Cr.. The value appears strong and on an upward trend. It has increased from 80.00 Cr. (Mar 2024) to 88.00 Cr., marking an increase of 8.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,558.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,577.00 Cr. (Mar 2024) to 1,558.00 Cr., marking a decrease of 19.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,880.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,854.00 Cr. (Mar 2024) to 2,880.00 Cr., marking an increase of 26.00 Cr..

However, the Borrowings (1,371.00 Cr.) are higher than the Reserves (1,081.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Avadh Sugar & Energy Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 43.93. This value is within the healthy range. It has decreased from 64.00 (Mar 24) to 43.93, marking a decrease of 20.07.
• For Diluted EPS (Rs.), as of Mar 25, the value is 43.93. This value is within the healthy range. It has decreased from 64.00 (Mar 24) to 43.93, marking a decrease of 20.07.
• For Cash EPS (Rs.), as of Mar 25, the value is 72.96. This value is within the healthy range. It has decreased from 91.61 (Mar 24) to 72.96, marking a decrease of 18.65.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 550.05. It has increased from 513.69 (Mar 24) to 550.05, marking an increase of 36.36.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 550.05. It has increased from 513.69 (Mar 24) to 550.05, marking an increase of 36.36.
• For Dividend / Share (Rs.), as of Mar 25, the value is 10.00. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,316.58. It has decreased from 1,345.52 (Mar 24) to 1,316.58, marking a decrease of 28.94.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 139.78. This value is within the healthy range. It has decreased from 166.60 (Mar 24) to 139.78, marking a decrease of 26.82.
• For PBIT / Share (Rs.), as of Mar 25, the value is 110.74. This value is within the healthy range. It has decreased from 138.99 (Mar 24) to 110.74, marking a decrease of 28.25.
• For PBT / Share (Rs.), as of Mar 25, the value is 67.89. This value is within the healthy range. It has decreased from 98.24 (Mar 24) to 67.89, marking a decrease of 30.35.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 43.93. This value is within the healthy range. It has decreased from 64.00 (Mar 24) to 43.93, marking a decrease of 20.07.
• For PBDIT Margin (%), as of Mar 25, the value is 10.61. This value is within the healthy range. It has decreased from 12.38 (Mar 24) to 10.61, marking a decrease of 1.77.
• For PBIT Margin (%), as of Mar 25, the value is 8.41. This value is below the healthy minimum of 10. It has decreased from 10.32 (Mar 24) to 8.41, marking a decrease of 1.91.
• For PBT Margin (%), as of Mar 25, the value is 5.15. This value is below the healthy minimum of 10. It has decreased from 7.30 (Mar 24) to 5.15, marking a decrease of 2.15.
• For Net Profit Margin (%), as of Mar 25, the value is 3.33. This value is below the healthy minimum of 5. It has decreased from 4.75 (Mar 24) to 3.33, marking a decrease of 1.42.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.98. This value is below the healthy minimum of 15. It has decreased from 12.45 (Mar 24) to 7.98, marking a decrease of 4.47.
• For Return on Capital Employeed (%), as of Mar 25, the value is 14.74. This value is within the healthy range. It has decreased from 20.31 (Mar 24) to 14.74, marking a decrease of 5.57.
• For Return On Assets (%), as of Mar 25, the value is 3.05. This value is below the healthy minimum of 5. It has decreased from 4.48 (Mar 24) to 3.05, marking a decrease of 1.43.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.26. This value is within the healthy range. It has increased from 0.25 (Mar 24) to 0.26, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.24. This value exceeds the healthy maximum of 1. It has decreased from 1.28 (Mar 24) to 1.24, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.91. It has decreased from 1.02 (Mar 24) to 0.91, marking a decrease of 0.11.
• For Current Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 1.5. It has increased from 1.05 (Mar 24) to 1.12, marking an increase of 0.07.
• For Quick Ratio (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 1. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.78. This value is below the healthy minimum of 4. It has decreased from 1.87 (Mar 24) to 1.78, marking a decrease of 0.09.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 22.76. This value is within the healthy range. It has increased from 15.62 (Mar 24) to 22.76, marking an increase of 7.14.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 13.70. This value is below the healthy minimum of 20. It has increased from 10.91 (Mar 24) to 13.70, marking an increase of 2.79.
• For Earning Retention Ratio (%), as of Mar 25, the value is 77.24. This value exceeds the healthy maximum of 70. It has decreased from 84.38 (Mar 24) to 77.24, marking a decrease of 7.14.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 86.30. This value exceeds the healthy maximum of 70. It has decreased from 89.09 (Mar 24) to 86.30, marking a decrease of 2.79.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.26. This value is within the healthy range. It has decreased from 4.09 (Mar 24) to 3.26, marking a decrease of 0.83.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 3. It has decreased from 2.57 (Mar 24) to 2.02, marking a decrease of 0.55.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,258.99. It has decreased from 2,380.42 (Mar 24) to 2,258.99, marking a decrease of 121.43.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has decreased from 0.88 (Mar 24) to 0.85, marking a decrease of 0.03.
• For EV / EBITDA (X), as of Mar 25, the value is 8.07. This value is within the healthy range. It has increased from 7.14 (Mar 24) to 8.07, marking an increase of 0.93.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.39 (Mar 24) to 0.33, marking a decrease of 0.06.
• For Retention Ratios (%), as of Mar 25, the value is 77.23. This value exceeds the healthy maximum of 70. It has decreased from 84.37 (Mar 24) to 77.23, marking a decrease of 7.14.
• For Price / BV (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 1.04 (Mar 24) to 0.81, marking a decrease of 0.23.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.39 (Mar 24) to 0.33, marking a decrease of 0.06.
• For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 24) to 0.09, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness